Quantcast

Latest Clinical trial Stories

2014-06-23 08:29:39

- Initiates Global Footprint, Diversifies Business, Enhances Long-term Growth Prospects - ANAHEIM, Calif., June 23, 2014 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that the transaction acquiring rights to Synacthen(®) and Synacthen(®) Depot from Novartis Pharma AG and Novartis AG in certain countries outside the U.S. has now closed. Available in more than forty countries for multiple indications, Synacthen (tetracosactide) is a synthetic 24 amino acid...

2014-06-23 08:27:20

SOUTH SAN FRANCISCO, Calif., June 23, 2014 /PRNewswire/ -- Velocity Pharmaceutical Development, LLC ("VPD") and Tigercat Pharma, Inc., ("Tigercat") announced today that they have met all regulatory requirements from Germany's BfArM to initiate a Phase II clinical trial of VPD-737 (serlopitant) in patients with prurigo nodularis. Separately, VPD is also conducting a Phase II clinical trial in the United States evaluating VPD-737 in patients with chronic pruritus. "Prurigo nodularis...

2014-06-23 04:20:31

LONDON, June 23, 2014 /PRNewswire/ -- Highlights: - Creation of an international CRO with complete service offering from Phase I to Phase IV post-authorisation studies - Appointment of a highly experienced Board, including Professor Trevor Jones CBE, Chairman, Ronald Openshaw, Chief Executive Officer and Professor Sir Christopher Evans, Non-Executive Director - Completed with GBP12.5m of funds raised from Welsh...

2014-06-20 08:23:49

Company Refutes Latest Feuerstein False Headline and Attacks BETHESDA, Md., June 20, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today refuted Adam Feuerstein's latest false headline and attack on the Company, and reaffirmed the Company's recent interim data announcements from its Phase I/II clinical trial of DCVax-Direct for all inoperable solid tumors....

2014-06-19 23:11:43

In this webinar, speakers Wendy Stewart, VP and Integrated Site Start up at Quintiles along with Sam Searcy, Associate Contracts Services Director and Global Regulatory Start Up at Quintiles, will demonstrate how some strategies, processes, and technology help maximize productivity and reduce cycle times. The live broadcast will be taking place on Thursday, July 10, 2014 at 11 a.m. EDT / 4p.m. BST (UK GMT +1). Toronto, Canada (PRWEB) June 19, 2014 In the early stages of a clinical study,...

2014-06-19 16:26:20

SAN DIEGO, June 19, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today announced that Howard C. Dittrich, M.D., F.A.C.C., has joined its Board of Directors. Dr. Dittrich, a cardiologist by training, has more than 20 years of experience in cardiac therapeutic research and clinical development. "We are delighted to welcome Howard to the Board," stated Jack Lief, Chair of Mast's Board of Directors. "His medical training and extensive clinical development and...

2014-06-19 08:28:24

REDWOOD CITY, Calif., June 19, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that senior management will present a corporate overview on June 25th. Presentation details are as follows: JMP Securities Healthcare ConferenceDate: Wednesday, June 25thLocation: The Westin New York Grand Central,...

2014-06-18 16:26:53

KANSAS CITY, Kan., June 18, 2014 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for cats, dogs and other companion animals, today announced that it is currently enrolling patients in two nationwide clinical trials to evaluate its monoclonal antibody for canine T-cell lymphoma, AT-005, which is conditionally licensed by the USDA to aid in the treatment of...

2014-06-18 08:24:53

MORRISTOWN, N.J., June 18, 2014 /PRNewswire/ -- Atlantic Health System has launched a new website that provides information about open and enrolling clinical trials and research studies across Atlantic Health System medical centers. The tablet and smartphone-friendly website, atlantichealth.org/research, features a search tool that allows visitors to easily find trials based on disease area, keywords, and the name of physicians conducting trials. Atlantic Health System, which...

2014-06-17 23:09:08

Wireless Solution Delivers Cost Savings and Real-time Access to Key Patient Data Philadelphia, PA (PRWEB) June 17, 2014 ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market its AM3® GSM devices in respiratory clinical trials. The AM3 GSM device provides a robust and reliable wireless option for clinical trial patients to...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related